These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 15355361)
1. Documenting dermatology practice: ratio of cutaneous tumors biopsied that are malignant. Green AR; Elgart GW; Ma F; Federman DG; Kirsner RS Dermatol Surg; 2004 Sep; 30(9):1208-9. PubMed ID: 15355361 [TBL] [Abstract][Full Text] [Related]
2. How informative are dermatopathology requisition forms completed by dermatologists? A review of the clinical information provided for 100 consecutive melanocytic lesions. Waller JM; Zedek DC J Am Acad Dermatol; 2010 Feb; 62(2):257-61. PubMed ID: 19962786 [TBL] [Abstract][Full Text] [Related]
3. Accuracy of teledermatology for nonpigmented neoplasms. Warshaw EM; Lederle FA; Grill JP; Gravely AA; Bangerter AK; Fortier LA; Bohjanen KA; Chen K; Lee PK; Rabinovitz HS; Johr RH; Kaye VN; Bowers S; Wenner R; Askari SK; Kedrowski DA; Nelson DB J Am Acad Dermatol; 2009 Apr; 60(4):579-88. PubMed ID: 19217689 [TBL] [Abstract][Full Text] [Related]
4. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic. Risser J; Pressley Z; Veledar E; Washington C; Chen SC J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623 [TBL] [Abstract][Full Text] [Related]
5. A dermoscopy survey to assess who is using it and why it is or is not being used. Noor O; Nanda A; Rao BK Int J Dermatol; 2009 Sep; 48(9):951-2. PubMed ID: 19702978 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the benign to malignant ratio of lesions biopsied by a general dermatologist before and after the adoption of dermoscopy. Terushkin V; Warycha M; Levy M; Kopf AW; Cohen DE; Polsky D Arch Dermatol; 2010 Mar; 146(3):343-4. PubMed ID: 20231514 [No Abstract] [Full Text] [Related]
7. Baseline factors influencing decisions on digital follow-up of melanocytic lesions in daily practice: an Italian multicenter survey. Carli P; Ghigliotti G; Gnone M; Chiarugi A; Crocetti E; Astorino S; Berti UA; Broganelli P; Carcaterra A; Corradin MT; Pellacani G; Piccolo D; Risulo M; Stanganelli I; De Giorgi V J Am Acad Dermatol; 2006 Aug; 55(2):256-62. PubMed ID: 16844508 [TBL] [Abstract][Full Text] [Related]
8. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma. Fisher NM; Schaffer JV; Berwick M; Bolognia JL J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344 [TBL] [Abstract][Full Text] [Related]
9. A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma. McKenna DB; Marioni JC; Lee RJ; Prescott RJ; Doherty VR Br J Dermatol; 2004 Sep; 151(3):636-44. PubMed ID: 15377351 [TBL] [Abstract][Full Text] [Related]
10. Factors leading to the biopsy of 1547 pigmented lesions at Mayo Clinic, Scottsdale, Arizona, in 2005. Soares TF; Laman SD; Yiannias JA; Connolly SM; Lim KK; Wu Q; Swanson DL Int J Dermatol; 2009 Oct; 48(10):1053-6. PubMed ID: 19775399 [TBL] [Abstract][Full Text] [Related]
11. Who else is providing care in dermatology practices? Trends in the use of nonphysician clinicians. Resneck JS; Kimball AB J Am Acad Dermatol; 2008 Feb; 58(2):211-6. PubMed ID: 18222319 [TBL] [Abstract][Full Text] [Related]
12. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France. Grange F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A Arch Dermatol; 2008 May; 144(5):629-36. PubMed ID: 18490589 [TBL] [Abstract][Full Text] [Related]
13. Generational differences in practice patterns of dermatologists in the United States: implications for workforce planning. Jacobson CC; Resneck JS; Kimball AB Arch Dermatol; 2004 Dec; 140(12):1477-82. PubMed ID: 15611425 [TBL] [Abstract][Full Text] [Related]
14. Management of cutaneous malignant melanoma by dermatologists of the American Academy of Dermatology. I. Survey of biopsy practices of pigmented lesions suspected as melanoma. Salopek TG; Slade J; Marghoob AA; Rigel DS; Kopf AW; Bart RS; Friedman RJ J Am Acad Dermatol; 1995 Sep; 33(3):441-50. PubMed ID: 7657868 [TBL] [Abstract][Full Text] [Related]
15. Factors associated with the number of lesions excised for each skin cancer: a study of primary care physicians in Queensland, Australia. Baade PD; Youl PH; Janda M; Whiteman DC; Del Mar CB; Aitken JF Arch Dermatol; 2008 Nov; 144(11):1468-76. PubMed ID: 19015421 [TBL] [Abstract][Full Text] [Related]
16. A retrospective biopsy study of the clinical diagnostic accuracy of common skin diseases by different specialties compared with dermatology. Sellheyer K; Bergfeld WF J Am Acad Dermatol; 2005 May; 52(5):823-30. PubMed ID: 15858472 [TBL] [Abstract][Full Text] [Related]
17. Age distribution of biopsied junctional nevi. Westhafer J; Gildea J; Klepeiss S; Clarke L; Helm K J Am Acad Dermatol; 2007 May; 56(5):825-7. PubMed ID: 17437890 [TBL] [Abstract][Full Text] [Related]
18. The management of skin malignancy: to what extent should we rely on clinical diagnosis? Brown SJ; Lawrence CM Br J Dermatol; 2006 Jul; 155(1):100-3. PubMed ID: 16792759 [TBL] [Abstract][Full Text] [Related]
19. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755 [TBL] [Abstract][Full Text] [Related]
20. Differences in biopsy techniques of actinic keratoses by plastic surgeons and dermatologists: a histologically controlled pilot study. Sellheyer K; Bergfeld WF Arch Dermatol; 2006 Apr; 142(4):455-9. PubMed ID: 16618864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]